ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $737,000 | +56.1% | 7,927 | 0.0% | 0.00% | +50.0% |
Q3 2021 | $472,000 | -12.8% | 7,927 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $541,000 | -1.6% | 7,927 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $550,000 | -9.7% | 7,927 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $609,000 | +2.7% | 7,927 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $593,000 | +18.8% | 7,927 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $499,000 | +49.8% | 7,927 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $333,000 | +8.1% | 7,927 | +17.0% | 0.00% | 0.0% |
Q4 2019 | $308,000 | -0.6% | 6,776 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $310,000 | -21.9% | 6,776 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $397,000 | +30.6% | 6,776 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $304,000 | +15.2% | 6,776 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $264,000 | -15.4% | 6,776 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $312,000 | +352.2% | 6,776 | +327.2% | 0.00% | – |
Q2 2018 | $69,000 | +9.5% | 1,586 | 0.0% | 0.00% | – |
Q1 2018 | $63,000 | +16.7% | 1,586 | 0.0% | 0.00% | – |
Q4 2017 | $54,000 | – | 1,586 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |